NEW DELHI, Nov. 10 -- Revised maximum retail prices (MRPs) of 1,364 anti-cancer medicine formulations came into effect across the country on Monday, with the Centre estimating annual savings of Rs 3,540.38 crore for consumers.

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, has capped trade margins on the MRPs of 137 anti-cancer drugs following recommendations of an expert committee constituted by the Directorate General of Health Services on October 17, 2026.

According to the NPPA, 85 pharmaceutical companies had reported revised MRPs for 1,364 formulations covering 121 drugs as of November 8.

Of these, 679 brands reported price reductions of more th...